A registered PHASE4 study indexed because it matched monitored longevity research terms. Registry status: Not Yet Recruiting. Registration does not establish safety or effectiveness.
What the source actually supports
- Evidence stage
- Phase 4
- Study design
- RANDOMIZED · PARALLEL · TREATMENT · QUADRUPLE
- Evidence population
- Human clinical study registration
- Participants
- 100
- Population
- ALL · 65 Years
- Duration
- 2026-04-01 to 2027-12-31
- Intervention
- Lemborexant; Placebo
- Comparator
- Placebo
- Outcomes measured
- Total Sleep Time Assessed by Actigraphy — Nights 1-3 of the intervention period (20:00 to 08:00 each night); Subjective Sleep Quality Assessed by Richards-Campbell Sleep Questionnaire — Each morning after Nights 1-3 of the inter…; Delirium Incidence Assessed by CAM-ICU — From randomization until ICU Day 7 or ICU discharge, whichever occurs first; Delirium Duration — From randomization until ICU Day 7 or ICU discharge, whichever occurs first; Objective Sleep Stage Proportions Assessed by Actigraphy — Nights 1-3 of the intervention period (20:00 to 08:00 each n…; Composite Sleep Score Assessed by Actigraphy — Nights 1-3 of the intervention period (20:00 to 08:00 each night).; Safety and Adverse Events — From the first dose of study medication until ICU discharge, assessed for up to 7 days afte…; Recruitment Rate — During the recruitment period, from first patient screened to last patient randomized.; Medication Adherence to Study Drug — Nights 1-3 of the intervention period; Completion Rate of Subjective Sleep Assessments — Each morning after Nights 1-3 of the intervention period (approximate…; Adequacy of Actigraphy Wear Time — Nights 1-3 of the intervention period (20:00 to 08:00 each night).
- Reported result
- No reusable finding-level result is available in this record.
Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.
Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.
Source supportStructured registry protocol metadata; no finding-level conclusion is generated.
Registration and recruitment status do not establish safety, efficacy, or regulatory approval.
Why this record appears here · 100% topic match
The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.
- Sleep · 100%Title contains controlled topic terminology. Summary contains controlled topic terminology. Source terminology contains a controlled topic term. Title supplies ageing or longevity context.
Automated source check 100% · update recency 85%. These figures help sort records; they are not medical ratings.